Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTHFD2P1 is a pseudogene of the methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) gene. Unlike the functional MTHFD2 enzyme, which is a mitochondrial enzyme involved in folate-mediated one-carbon metabolism and is a notable therapeutic target in oncology, MTHFD2P1 does not encode an active protein[1][2][3]. Pseudogenes like MTHFD2P1 may be remnants of evolutionary duplication events and, unless shown otherwise, are not considered functional targets in pharmacology or biomedical research. If your intention is to research a metabolic enzyme or therapeutic target, focus should be on MTHFD2, not MTHFD2P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylenetetrahydrofolate dehydrogenase 2, methenyltetrahydrofolate cyclohydrolase pseudogene 1 (MTHFD2P1).